Anni Skovbo

538 total citations
13 papers, 403 citations indexed

About

Anni Skovbo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Anni Skovbo has authored 13 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Anni Skovbo's work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anni Skovbo is often cited by papers focused on Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anni Skovbo collaborates with scholars based in Denmark, Netherlands and United States. Anni Skovbo's co-authors include Marianne Hokland, Kirsten Grønbæk, Mette Skov Holm, Andreas Due Ørskov, Lone S. Friis, Marianne Bach Treppendahl, Peter J.K. Kuppen, N. de Vries, Morten Nørgaard Andersen and Daniëlle Krijgsman and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Oncotarget.

In The Last Decade

Anni Skovbo

13 papers receiving 400 citations

Peers

Anni Skovbo
Marta Cuenca Netherlands
Sanne Hiddingh Netherlands
Philip McCoy United States
Sheila Dias United States
Yu Abe Japan
Arafat Aljoufi United States
Anni Skovbo
Citations per year, relative to Anni Skovbo Anni Skovbo (= 1×) peers Tina Nuebling

Countries citing papers authored by Anni Skovbo

Since Specialization
Citations

This map shows the geographic impact of Anni Skovbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anni Skovbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anni Skovbo more than expected).

Fields of papers citing papers by Anni Skovbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anni Skovbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anni Skovbo. The network helps show where Anni Skovbo may publish in the future.

Co-authorship network of co-authors of Anni Skovbo

This figure shows the co-authorship network connecting the top 25 collaborators of Anni Skovbo. A scholar is included among the top collaborators of Anni Skovbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anni Skovbo. Anni Skovbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Krijgsman, Daniëlle, N. de Vries, Morten Nørgaard Andersen, et al.. (2020). The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma. Cancer Immunology Immunotherapy. 69(10). 2009–2020. 10 indexed citations
2.
Krijgsman, Daniëlle, N. de Vries, Morten Nørgaard Andersen, et al.. (2020). CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood. International Journal of Molecular Sciences. 21(16). 5925–5925. 30 indexed citations
3.
Krijgsman, Daniëlle, N. de Vries, Anni Skovbo, et al.. (2019). Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Cancer Immunology Immunotherapy. 68(6). 1011–1024. 115 indexed citations
4.
Ørskov, Andreas Due, Marianne Bach Treppendahl, Anni Skovbo, et al.. (2015). Hypomethylation and up-regulation ofPD-1in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation. Oncotarget. 6(11). 9612–9626. 150 indexed citations
5.
Nederby, Line, et al.. (2014). Relevance of sCD163 As a Prognostic Biomarker in Chronic B-Cell Lymphocytic Leukemia. Blood. 124(21). 5643–5643. 1 indexed citations
6.
Skovbo, Anni, et al.. (2011). Development of a flow cytometry assay combining cell proliferation, viability and two specific surface markers. Medicina Universitaria. 13(53). 183–192. 2 indexed citations
7.
Petersen, Charlotte Christie, Line Nederby, Anne Stidsholt Roug, et al.. (2011). Increased Expression of CD69 on T Cells as an Early Immune Marker for Human Cytomegalovirus Reactivation in Chronic Lymphocytic Leukemia Patients. Viral Immunology. 24(2). 165–169. 4 indexed citations
8.
Nederby, Line, Thomas Harbo, Anni Skovbo, et al.. (2011). The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology. 18(6). 919–924. 23 indexed citations
9.
Eskelund, Christian Winther, Line Nederby, Anna Hammerich Thysen, et al.. (2011). Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia. Leukemia Research. 35(7). 914–920. 16 indexed citations
10.
Roug, Anne Stidsholt, et al.. (2009). The CD94/NKG2C-Expressing NK Cell Subset Is Augmented in Chronic Lymphocytic Leukemia Patients with Positive Human Cytomegalovirus Serostatus. Viral Immunology. 22(5). 333–337. 15 indexed citations
12.
Kjaergäard, Jørgen, et al.. (2000). Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animals. Cancer Immunology Immunotherapy. 48(10). 550–560. 22 indexed citations
13.
Olesen, G., et al.. (1998). Delineation of erythropoiesis in normal and malignant bone marrow using monoclonal antibody AS‐E1 directed against transferrin receptors (CD71). European Journal Of Haematology. 60(1). 53–60. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026